0000939767-22-000100.txt : 20220812
0000939767-22-000100.hdr.sgml : 20220812
20220812202326
ACCESSION NUMBER: 0000939767-22-000100
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220811
FILED AS OF DATE: 20220812
DATE AS OF CHANGE: 20220812
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Senner Christopher J.
CENTRAL INDEX KEY: 0001648367
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 221161964
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
4
1
wf-form4_166035018251392.xml
FORM 4
X0306
4
2022-08-11
0
0000939767
EXELIXIS, INC.
EXEL
0001648367
Senner Christopher J.
C/O EXELIXIS, INC.
1851 HARBOR BAY PARKWAY
ALAMEDA
CA
94502
0
1
0
0
EVP and CFO
Common Stock
2022-08-11
4
M
0
225000
6.21
A
670882
D
Common Stock
2022-08-11
4
F
0
152867
19.23
D
518015
D
Common Stock
2723
I
By 401(k)
Option (right to buy)
6.21
2022-08-11
4
M
0
225000
0
D
2016-09-16
2022-09-15
Common Stock
225000.0
0
D
Includes 166,412 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units.
Represents a "net exercise" of an outstanding stock option. The Reporting Person received 225,000 shares of Common Stock on the net exercise of a stock option to purchase 72,133 shares of Common Stock. The Issuer withheld 152,867 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using the closing price of Common Stock on August 11, 2022 of $19.23.
Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of August 11, 2022.
The option, representing the right to purchase a total of 225,000 shares of Common Stock, became fully exercisable on September 16, 2019.
/s/ Nina Ayer, Attorney in Fact
2022-08-12